501-588

501. Kligfield P, Levy D, Devereux RB, et al. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J 1987; 113: 1298-1307.

502. Grigioni F, Enriquez, Sarano M, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 1999; 34: 2078-2085.

503. Kligfield P, Hochreiter C, Kramer H, et al. Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias

　in mitral valve prolapse without mitral regurgitation. Am J Cardiol 1985; 55: 1545-1549.

504. Winkle RA, Lopes MG, Fitzgerald JW, et al. Arrhythmias in patients with mitral valve prolapse. Circulation 1975; 52: 73-81.

505. DeMaria AN, Amsterdam EA, Vismara LA, et al. Arrhythmias in the mitral valve prolapse syndrome. Prevalence, nature, and frequency. Ann Intern

　Med 1976; 84: 656-660.

506. Campbell RW, Godman MG, Fiddler GI, et al. Ventricular arrhythmias in syndrome of balloon deformity of mitral valve. Definition of possible high risk

　group. Br Heart J 1976; 38: 1053-1057.

507. Savage DD, Garrison RJ, Devereux RB, et al. Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am

　Heart J 1983; 106: 571-576.

508. Baudet EM, Puel V, McBride JT, et al. Long-term results of valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1995;

　109: 858-870.

509. Fernandez J, Laub GW, Adkins MS, et al. Early and latephase events after valve replacement with the St. Jude Medical prosthesis in 1200 patients.

　J Thorac Cardiovasc Surg. 1994; 107: 394-406.

510. Rooney SJ, Moreno de la Santa P, Lewis PA, et al. Sudden death in a large prosthetic valve series based on a single prosthesis: experience with

　the Medtronic Hall valve. J Heart Valve Dis 1994; 3: 5-9.

511. Debetaz LF, Ruchat P, Hurni M, et al. Medical valve prosthesis: an analysis of long-term outcome and prognostic factors J Thorac Cardiovasc Surg

　1997; 113: 134-148.

512. Aupart M, Simonnot I, Sirinelli A, et al. Pericardial valves in small aortic annuli: ten years' results. Eur J Cardiothorac Surg 1996; 10: 879-883.

513. Torka MC, Salefsky BE, Hacker RW. Intermediate clinical results after aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis.

　Ann Thorac Surg 1995; 60 (2 Suppl): S311-315.

514. Sato N, Mohri H, Kagawa Y, et al. Real time sound spectral analysis for diagnosis of thrombosed prosthetic valves. ASAIO Trans 1988; 34: 831-834.

515. Bjork VO, Henze A, Hindmarsh T. Radiopaque marker in the tilting disc of the Bjork-Shiley heart valve. Evaluation of in vivo prosthetic valve function

　by cineradiography. J Thorac Cardiovasc Surg 1977; 73: 563-569.

516. 学校管理下の死亡・障害（昭和63年度版）．日本体育・学校健康センター学校安全部発行．文唱堂 1988: 204-219.

517. 加藤裕久，岡田了三，関口守衛，他．若年者心疾患における突然死の実態と予防に関する研究 Jpn Cir J 1998; 62 (Suppl Ⅱ) : 781-787.

518. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 2001; 50: 399-408.

519. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991; 68: 1388-1392.

520. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome, New Eng J Med 1998;

　238: 1709-1714.

521. Schwartz PJ, Montemerlo M, Facchini M, et al. The QT interval throughout the first six months of life:a prospective study, Circulation 1982; 66; 496

　-501.

522. Goldhammer EI, Zaid G, Tal V, et al. QT dispersion in infants with apparent life-threatening events syndrome. Pediatr Cardiol 2002; 23: 605-607.

523. Zupancic JA, Triedman JK, Alexander M, et al. Costeffectiveness and implications of newborn screening for prolongation of QT interval for the

　prevention of sudden infant death syndrome. J Pediatr 2000; 136: 481-489.

524. Rhodes TE, Abraham RL, Welch RC, et al. Cardiac potassium channel dysfunction in sudden infant death syndrome. J Mol Cell Cardiol 2008; 44:

　571-581.

525. Millat G, Kugener B, Chevalier P, et al. Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr Cardiol 2009;

　30: 502-509.

526. Wu G, Ai T, Kim JJ, et al. alpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption. Circ Arrhythm

　Electrophysiol 2008; 1: 193-201.

527. Wang DW, Crotti L, Shimizu W, et al. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.

　Circ Arrhythm Electrophysiol 2008; 1: 370-378.

528. Cheng J, Van Norstrand DW, Medeiros-Domingo A, et al. Alpha1-syntrophin mutations identified in sudden infant death syndrome cause an increase

　in late cardiac sodium current. Circ Arrhythm Electrophysiol 2009; 2: 667-676.

529. Tester DJ, Dura M, Carturan E, et al. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart

　Rhythm 2007; 4: 733-739.

530. Paz Suarez-Mier M, Aguilera B. Histopathology of the conduction system in sudden infant death. Forensic Sci Int 1998; 93: 143-154.

531. Smith NM, Ho SY. Heart block and sudden death associated with fibrosis of the conduction system at the margin of a ventricular septal defect.

　Pediatr Cardiol 1994; 15: 139-142.

532. Bonnet D, Martin D, Pascale De Lonlay, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in

　children. Circulation 1999; 100: 2248-2253.

533. Meny RG, Carroll JL, Carbone MT, et al. Cardiorespiratory recordings from infants dying suddenly and unexpectedly at home.Pediatrics 1994; 93:

　44-49.

534. Ramanathan R, Corwin MJ, Hunt CE, et al. Collaborative Home Infant Monitoring Evaluation (CHIME) Study Group. Cardiorespiratory events recorded

　on home monitors: Comparison of healthy infants with those at increased risk for SIDS. JAMA 2001; 285: 2199-2207.

535. Daniels H, Naulaers G, Deroost F, et al. Polysomnography and home documented monitoring of cardiorespiratory pattern. Arch Dis Child 1999; 81:

　434-436.

536. Cote A, Hum C, Brouillette RT, et al. Frequency and timing of recurrent events in infants using home cardiorespiratory monitors. J Pediatr 1998; 312:

　783-789.

537. Davis AM, Gow RM, McCrindle BW, et al. Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young

　children. Am Heart J 1996; 131: 186-191.

538. Silka MJ, Kron J, Walance CG, et al. Assessment and follow-up of pediatric survivors of sudden cardiac death. Circulation 1990; 82: 341-349.

539. Fukushige T, Yoshinaga M, Shimago A, et al. Effect of age and overweight on the QT interval and the prevalence of long QT syndrome in children.

　Am J Cardiol 2002; 89: 395-398.

540. Horigome H, Nagashima M, Sumitomo N, et al. Clinical characteristics and genetic background of congenital long QT syndrome diagnosed in fetal,

　neonatal and infantile life. A nation-wide questionnaire survey in Japan. Circ Arrhythm Electrophysiol 2010; 3: 10-17.

541. Yoshinaga M, Nagashima M, Shibata T, et al. Who is at risk for cardiac events in young patients with long QT syndrome? Circ J 2003; 67: 1007-1012.

542. Alexander ME, Cecchin F, Walsh EP, et al. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J

　Cardiovasc Electrophysiol 2004; 15: 72-76.

543. Korte T, Koditz H, Niehaus M, et al. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable

　cardioverter defibrillator. Pacing Clin Electrophysiol 2004; 27: 924-932.

544. Cooper JM, Stephenson EA, Berul CI, et al. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults

　with congenital heart disease: implications for implantation and management. J Cardiovasc Electrophysiol 2003; 14: 344-349.

545. Stefanelli CB, Bradley DJ, Leroy S, et al. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card

　Electrophysiol 2002; 6: 235-244.

546. Chatrath R, Porter CB, Ackerman MJ. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children,

　adolescents, and young adults. Mayo Clin Proc 2002; 77: 226-231.

547. Goel AK, Berger S, Pelech A, et al. Implantable cardioverter defibrillator therapy in children with long QT syndrome. Pediatr Cardiol 2004; 25: 370-378.

548. 吉永正夫，新村一郎，長嶋正實，他．QT延長症候群患児の管理基準に関する研究委員会報告．日本小児循環器学会雑誌 2004; 20: 52-53.

549. Roden DM. The problem, challenge and opportunity of genetic heterogeneity in monogenic diseases predisposing to sudden death. J Am Coll Cardiol

　2002; 40: 357-359.

550. James TN, St Martin E, Willis PW, et al. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias

　associated with absence of the AV node, sinus node, and internodal pathways. Circulation 1996; 93: 1424-1438.

551. Bharati S, Lev M. Cardiac conduction system involvement in sudden death of obese young people. Am Heart J 1995; 129: 273-281.

552. Bharati S, Lev M. The conduction system findings in sudden cardiac death. J Cardiovasc Electrophysiol 1994; 5: 356-366.

553. Okada R, Kawai S. Histopathology of the conduction system in sudden cardiac death. Jpn Circ J 1983; 47: 573-580.

554. Cohle SD, Suarez-Mier MP, Aguilera B. Sudden death resulting from lesions of the cardiac conduction system. Am J Forensic Med Pathol 2002; 23:

　83-89.

555. Link MS, Wang PJ, Maron BJ, et al. What is commotio cordis? Cardiol Rev 1999; 7: 265-269.

556. Maron BJ, Gohman TE, Kyle SB, et al. Clinical profile and spectrum of commotio cordis. JAMA 2002; 287: 1142-1146.

557. Link MS, Wang PJ, Pandian NG, et al. An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis) N Engl J Med

　1998; 338: 1805-1811.

558. Maron BJ, Link MS, Wang PJ, et al. Clinical profile of commotio cordis: an under appreciated cause of sudden death in the young during sports and

　other activities. J Cardiovasc Electrophysiol 1999; 10: 114-120.

559. Link MS, Wang PJ, VanderBrink BA, et al. Selective activation of the K (+) (ATP) channel is a mechanism by which sudden death is produced by low

　-energy chest-wall impact (Commotio cordis). Circulation 1999; 100: 413-418.

560. Madias C, Maron BJ, Alsheikh-Ali AA, et al. Precordial thump for cardiac arrest is effective for asystole but not for ventricular fibrillation. Heart Rhythm

　2009; 6: 1495-1500.

561. Link MS, Maron BJ, Wang PJ, et al. Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs. Pediatrics 2002;

　109: 873-877.

562. Silka MJ, Hardy BG, Menashe VD, et al. A populationbased prospective evaluation of risk of sudden cardiac death after operation for common

　congenital heart defects. J Am Coll Cardiol 1998; 32: 245-251.

563. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol 2007; 50:

　1263-1271.

564. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre

　study. Lancet 2000; 356: 975-981.

565. Ghai A, Silversides C, Harris L, et al. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of

Fallot.

　J Am Coll Cardiol 2002; 40: 1675-1680.

566. Nollert G, Fischlein T, Bouterwek S, et al. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first

　year after surgical repair. J Am Coll Cardiol 1997; 30: 1374-1383.

567. Hamada H, Terai M, Jibiki T, et al. Influence of early repair of tetralogy of fallot without an outflow patch on late arrhythmias and sudden death: a 27

　-year follow-up study following a uniform surgical approach. Cardiol Young 2002; 12: 345-351.

568. Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation

　2001; 103: 2489-2494.

569. Hokanson JS, Moller JH. Significance of early transient complete heart block as a predictor of sudden death late after operative correction of tetralogy

　of Fallot.Am J Cardiol 2001; 87: 1271-1277.

570. Nakazwa M, Shinohara T, Sasaki A, et al. Arrhtyhmias late after repair of tetralogy of Fallot- A Japanese Multicenter Study-. Circ J 2004; 68: 126-130.

571. Sakazaki H, Niwa K, Echigo S, et al. Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease--Japanese multi-center

　study. Int J Cardiol 2007; 120: 72-78.

572. Dore A, Santagata P, Dubuc M, et al. Implantable cardioverter defibrillators in adults with congenital heart disease: a single center experience

. Pacing Clin Electrophysiol 2004; 27: 47-51.

573. Silka MJ, Kron J, Dunnigan A, et al. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric

　Electrophysiology Society. Circulation 1993; 87: 800-807.

574. 循環器病の診断と治療に関するガイドライン．成人先天性心疾患診療ガイドライン（2006年改訂版）．http://www.j-circ.or.jp/guideline/pdf/JCS2006

　_kurosawa_h.pdf（2010 年6月閲覧）．

575. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report

　of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/

　AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American

　Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-408.

576. Kitada M, Uheda K, Yasutake K, et al. The problems in controlling heart disease among elementary, junior and senior high school students-an

　analysis of fatal cases. Jpn Circ J 1983; 47: 1340-1346.

577. 衣川佳数，中沢　誠，門間和夫，他．小児期発症の肥大型心筋症の自然歴．日本小児循環器学会雑誌1992; 8: 402-412.

578. 西川俊郎，佐地勉，唐澤賢祐，他．小児期肥大型心筋症全国調査成績．日本小児循環器学会雑誌 2008; 4: 572-574.

579. 三沢正弘，大塚正弘，山口英夫，他．小児期肥大型心筋症23例の臨床経過について．日本小児循環器学会雑誌1990; .6: 387-392.

580. Yasui K, Shibata T, Nishizawa T, et al. Response of the stroke volume and blood pressure of young patients with nonobstructive hypertrophic

　cardiomyopathy to exercise. Jpn Circ J, 2001; 65: 300-304.

581. Yetman AT, Hamilton RM, Benson LN. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll

　Cardiol 1998; 32: 1943-1950.

582. Ostman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following highdose

　betaadrenoceptor antagonist treatment. J Am Coll Cardiol 1999; 34: 1813-1822.

583. Ostman-Smith I, Wettrell G, Keeton B, et al. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. Eur Heart J 2008;

　29:1160-1167.

584. Decker JA, Rossano JW, Smith EO, et al. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol

　2009; 54: 250-254.

585. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

　Circulation 2009; 119: 1085-1092.

586. 日本川崎病運営委員会．川崎病の管理基準（2002年改訂）．日本小児科学会雑誌 2003; 107: 166-167.

587. 循環器病の診断と治療に関するガイドライン．川崎病心臓血管後遺症の診断と治療に関するガイドライン（2008年改訂版）．

http://www.j-circ.or.jp/guideline/pdf/JCS2007_ogawasy_h.pdf（2010年6月閲覧）．．

588. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health

　professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American

　Heart Association. Circulation 2004; 110: 2747-2771.

文献